Company profile

Ortoma AB

Surgical AI & Robotics

Company profile

About Ortoma AB

Ortoma AB is a Swedish medical technology company that develops AI-assisted surgical solutions for orthopedic procedures. The company's flagship product, the Ortoma Treatment Solution (OTS™), is a server-based artificial intelligence platform designed to support orthopedic joint and spine surgery. The platform integrates advanced machine learning algorithms to drastically reduce pre-operative planning time, performing automated AI analysis that generates bone segmentation, landmarks, implant size, and implant position suggestions in minutes. Surgeons can then fine-tune and validate plans through an intuitive interface before surgery. The OTS™ platform connects pre-operative planning with precision surgical navigation and post-operative verification, enabling surgeons to control the entire surgical process from planning to follow-up. Ortoma currently focuses on hip arthroplasty and spine surgery, with the goal of improving patient lives by providing surgeons with disruptive surgical technologies that optimize medical outcomes. The company's mission is to provide intuitive, precision cutting-edge solutions to improve outcomes in orthopedic surgeries, enabling surgeons to achieve optimized results for patients, surgeons, and hospitals. Ortoma's products have received regulatory clearances including FDA 510(k) approval, CE marking, and PMDA certification for hip replacement surgery solutions. The company is ISO 13485 certified for its quality management system and maintains compliance with medical device regulations including U.S. 21 CFR820. Ortoma is headquartered in Gothenburg, Sweden, and is publicly traded.

Company description Ortoma AB official website

Primary marketSurgical AI & Robotics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Ortoma AB?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Hip arthroplasty
  • Orthopedic joint surgery
  • Spine surgery
  • Total hip replacement

Who it serves

  • Clinics
  • Hospitals
  • Orthopedic surgeons

Deployment & integration

Cloud Saas deployment with recorded integration context.

Geographic context

MarketsEurope · Japan · United Kingdom · United States
Company sourceOfficial website

Company milestones

Platform expansion

FDA 510(k) clearance for OTS™ Hip in US (March 2024), UK regulatory registration for OTS™ Hip (March 2026), PMDA certification in Japan, product launch in Japan with Johnson & Johnson K.K. (May 2023), appointed new CEO Fredrik Strömberg (February 2025)

Partnerships

Recorded partners

  • DePuy Synthes (term sheet for customized OTS Hip version)
  • Johnson & Johnson K.K. (Japan)

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Ortoma Treatment Solution (OTS™)

AI-assisted surgical planning, navigation, and verification platform for orthopedic procedures

Platform · Cloud SaaSCompany source

OTS™ Hip Guide

Surgical navigation system for hip replacement procedures

Software · Cloud SaaSCompany source

OTS™ Hip Plan

AI-powered pre-operative planning solution for hip arthroplasty

Software · Cloud SaaSCompany source

OTS™ Spine Plan

AI-assisted pre-operative planning for spine surgery

Software · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Reduced pre-operative planning time

AI analysis generates surgical plans in minutes versus traditional manual planning

Improved surgical accuracy

Precision surgical navigation and automated planning

Time efficiency

Pre-operative planning instantly available in operating room

Johnson & Johnson K.K. (Japan)

Clinical evaluation and launch of OTS™ Hip solution in Japanese market

DePuy Synthes

Development and distribution agreement for customized version of OTS Hip

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Fredrik Strömberg

CEO

Dr. Andreas Pettersson

Head of Clinical Operations

Anna Zyla

Head of Operations

Carianne Nilsson

Head of Sales and Marketing

Hassan Nemati

Head of Technical Research

Fredrik Hedberg

Head of QA/RA

Yvonne Mårtensson

Chairman of the Board

Gisli Hennermark

Board Member

06 · Company updates

Updates from Ortoma AB

Recent articles published on Ortoma AB's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Surgical AI & Robotics

Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon